This interview examines the use of KIR genotyping during donor selection and its association with improved outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation.
Katy Rezvani, MD, PhD
Advertisement
Articles by Katy Rezvani, MD, PhD
Advertisement
Latest Updated Articles
Using KIR Genotyping to Improve Transplant SuccessPublished: January 5th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves T-DXd Plus Pertuzumab in Metastatic HER2+ Breast Cancer
2
ASH 2025: The Top 10 Takeaways for Hematologic Oncology Care
3
FDA Grants National Priority Voucher to Teclistamab/Daratumumab in RRMM
4
Omitting Sentinel Lymph Node Biopsy Is Safe in Select Patients With HR+ Early Breast Cancer
5
